$0.00
(0.00%
) Quote details
USD
$0.00
(0.00%
)At Close (As of Dec 12, 2025)
$250.04M
Market Cap
-
P/E Ratio
-1.67
EPS
$4.53
52 Week High
$1.08
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
C4 Therapeutics, Inc. is an innovative biopharmaceutical company based in Watertown, Massachusetts, focused on developing advanced therapeutic candidates that selectively target and degrade disease-causing proteins. Specializing in oncology and neurodegenerative diseases, the company's proprietary dynamic protein degradation platform utilizes state-of-the-art biological mechanisms to offer groundbreaking treatment solutions for patients with significant unmet medical needs. Positioned as a leader in the biopharmaceutical industry, C4 Therapeutics is dedicated to transforming patient care by redefining treatment paradigms and improving clinical outcomes through its pioneering approaches.
LPTX
NVDA
CGC
PLUG
WOK
ASST
TSLA
AVGO
KIND
TLRY
INTC
KAVL
TNYA
ADAP
ORCL
SOFI
WULF
PLTD
DNN
AAL
MARA
PLTR
F
RR
APLT
PFE
BYND
IRBT
NFLX
CLSK
KVUE
ASBP
IREN
BITF
MTSR
AMD
RKLB
NIO
CIFR
FI
WBD
HOOD
QBTS
SNAP
GOOGL
BAC
VALE
CAN
SOUN
T
IVP
GRAB
AG
SMR
BTBT
NOK
HPE
CDE
RIG
DVLT
CMG
BLNK
MU
APLD
HL
LPTX
NVDA
CGC
PLUG
WOK
ASST
TSLA
AVGO
KIND
TLRY
INTC
KAVL
TNYA
ADAP
ORCL
SOFI
WULF
PLTD
DNN
AAL
MARA
PLTR
F
RR
APLT
PFE
BYND
IRBT
NFLX
CLSK
KVUE
ASBP
IREN
BITF
MTSR
AMD
RKLB
NIO
CIFR
FI
WBD
HOOD
QBTS
SNAP
GOOGL
BAC
VALE
CAN
SOUN
T
IVP
GRAB
AG
SMR
BTBT
NOK
HPE
CDE
RIG
DVLT
CMG
BLNK
MU
APLD
HL